Assessment of respiratory muscle strength in motor neurone disease: Is asking enough?

European Respiratory Journal

Volumn 35, Issue 2, 2010, Pages 245-246

  Murphy, P ^a   Lyall, R ^a   Hart, N ^b   Polkey, M I ^c  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTIFICIAL VENTILATION; BREATHING MUSCLE; DYSPNEA; EDITORIAL; HYPERCAPNIA; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; RESPIRATORY FAILURE; TERMINAL CARE; VITAL CAPACITY;

HUMANS; HYPERCAPNIA; MOTOR NEURON DISEASE; OXIMETRY; PULMONARY MEDICINE; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MUSCLES; VITAL CAPACITY;

EID: 76149119457     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00167509     Document Type: Editorial

References (18)

1. Bourke SC, Tomlinson M, Williams TL, et al. Effects of noninvasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006; 5: 140-147.
2. Lyall RA, Donaldson N, Fleming T, et al. A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001; 57: 153-156.
3. Mustfa N, Walsh E, Bryant V, et al. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006; 66: 1211-1217.
4. Chatwin M, Nickol AH, Morrell MJ, et al. Randomised trial of inpatient versus outpatient initiation of home mechanical ventilation in patients with nocturnal hypoventilation. Respir Med 2008; 102: 1528-1535.
5. Raphaël JC, Chevret S, Chastang C, et al. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet 1994; 343: 1600-1604.
6. Ward S, Chatwin M, Heather S, et al. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019-1024.
7. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66-72.
8. Hadjikoutis S, Wiles CM. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scand 2001; 103: 207-213.
9. Lyall RA, Donaldson N, Polkey MI, et al. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124: 2000-2013.
10. Allen SM, Hunt B, Green M. Fall in vital capacity with posture. Br J Dis Chest 1985; 79: 267-271.
11. DeTroyer A, Borenstein S, Cordier R. Analysis of volume restriction in patients with respiratory muscle weakness. Thorax 1980; 35: 603-610.
12. Man WD, Moxham J, Polkey MI. Magnetic stimulation for the measurement of respiratory and skeletal muscle function. Eur Respir J 2004; 24: 846-860.
13. Uldry C, Fitting J-W. Maximal values of sniff nasal inspiratory pressures in healthy subjects. Thorax 1995; 50: 371-375.
14. Steier J, Kaul S, Seymour J, et al. The value of multiple tests of respiratory muscle strength. Thorax 2007; 62: 975-980.
15. Morgan RK, McNally S, Alexander M, et al. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2005; 171: 269-274.
16. Chaudri MB, Liu C, Watson L, et al. Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease. Eur Respir J 2000; 15: 539-542.
17. Fitting JW, Paillex R, Hirt L, et al. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 1999; 46: 887-893.
18. Just N, Bautin N, Danel-Brunaud V, et al. The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosis. Eur Respir J 2010; 35: 353-360.